Skip to content
  • Mediacenter
  • Literature Database
  • Press
  • Investor News
USA (English)
Locale
CytoSorbents Europe GmbH
USA (English)
Locale
Hotline
  • About us
  • CytoSorbents worldwide
  • Scientific partners
  • Get in Contact

 Webinar-Reihe Medizincontrolling: Wissen kompakt – Dezember 2022

Zweckbestimmung von Medizinprodukten: On-Label, Off-Label, Misuse?

Update on CytoSorb® therapy in rhabdomyolysis | Webinar Rhabdomyolysis | 2022

Update on CytoSorb® therapy in liver dysfunction | Webinar Liver

Hemoadsorption with CytoSorb ® as part of an individualized therapy in critically ill patients

SIP OF SCIENCE No.5 with Marijana | CytoSorb® Therapy in Cardiac Surgery

Hemoadsorption in cardiac surgery – New data and trends for successful use of CytoSorb

Hämoadsorption in der Herzchirurgie – Neue Daten und Trends für einen erfolgreichen Einsatz von CytoSorb

Webinar CytoSorbents: “Hämoadsorption in der Intensivmedizin”

Webinar: Hemoadsorption in Critical Care

Webinar-Reihe Medizincontrolling: Wissen kompakt September

Untersuchungs- und Behandlungsmethoden im stationären Bereich: Wirtschaftlichkeit & Qualität

  • 1
  • 2
  • 3
  • ...
  • 33
  • Next
CytoSorbents Europe GmbH
Facebook-f Twitter Linkedin Youtube

CytoSorbents Europe GmbH
Müggelseedamm 131
12587 Berlin

support(at)cytosorbents.com

©2023 CYTOSORBENTS EUROPE GMBH | ALL RIGHTS RESERVED

*CytoSorb Therapy is the use of the CytoSorb adsorber in conditions where elevated levels of Cytokines and/or Bilirubin and/or Myoglobin exist. CytoSorb can also be used intraoperatively for the removal of Ticagrelor and/or Rivaroxaban during Cardiopulmonary-Bypass.

  • Privacy Information
  • Data protection
  • Disclaimer
  • Imprint
CytoSorbents Europe GmbH
  • About us
  • CytoSorbents worldwide
  • Scientific partners
  • Get in Contact
APPLY TODAY
JOBS
USA (English)
  • Privacy Policy
  • Data protection
  • Disclaimer
  • Imprint